What major milestone did archTIS (ASX:AR9) achieve with the US military?

The United States Department of Defense (U.S. DoD) successfully completed final internal production testing for archTIS’ flagship data security product, NC Protect.

Why did the U.S. Department of Defense prioritise testing archTIS (ASX:AR9) software?

Despite the operational strain of ongoing military operations in the Middle East, the U.S. DoD fast-tracked the assessment to conclude on 30 April 2026.

What specific technical capabilities of archTIS' NC Protect were validated?

The trials rigorously validated NC Protect’s Attribute-Based Access Control (ABAC) data segregation capabilities. Testing covered complex security scenarios involving both U.S. personnel and releasable users, leaving zero remaining technical barriers to deployment.

How does this news change the medium-term investment thesis for archTIS (ASX:AR9)?

This successful evaluation shifts archTIS from a speculative vendor to a validated military-grade software provider. The flawless testing results strongly position the company to secure a potential short-to-near-term commercial procurement mandate within the U.S. DoD.

What is the current share price and market context for archTIS (ASX:AR9) after this announcement?

At the time of reporting, the archTIS share price was trading at $0.065. This major technical validation provides a significant fundamental catalyst, though commercial revenues from the trial are still pending negotiation.

What are the main bull and bear points for archTIS (ASX:AR9) following this update?

The main bull point is the authoritative endorsement by the world's largest military, proving the software's mission readiness. The primary bear point is that a successful technical trial is not yet a guaranteed commercial contract, meaning timing on actual revenue remains uncertain.

Image for illustrative purposes only. Not a real photo.

archTIS shares surge following perfect Pentagon results

Written by Mahathir BayenaPublished May 27, 2026, 5:30 AM

Australian cyber-security firm archTIS (ASX:AR9) has achieved a milestone with the United States Department of Defence completing final production testing of its flagship data security product, NC Protect.

Despite the operational strain of ongoing military operations in the Middle East, the US DoD prioritised the testing, committing resources to conclude the final internal set of Warfighter Command production tests on April 30.

The tactical urgency underscores the critical demand for robust, data-centric security tools within high-assurance defence environments.

According to an official evaluation report issued by the US DoD on May 20, NC Protect achieved a flawless 100 per cent result, successfully passing all 60 assessed test cases.

The evaluation rigorously validated the platform's attribute-based access control data segregation capabilities, spanning complex scenarios involving US personnel and releasable users.

The comprehensive assessment left zero remaining technical barriers, providing an authoritative endorsement of the software's mission readiness and suitability for sensitive deployment.

The unblemished technical validation, paired with the operational priority demonstrated by the US military, positions ArchTIS strongly for a potential short-to-near-term mandate within the US DoD.

At the time of reporting, archTIS’ share price was $0.065.